Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

40%(2 trials)

Phase Distribution

Ph not_applicable

40%

Ph phase_2

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

2(50.0%)

N/ANon-phased studies

2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 22 (50.0%)

N/A2 (50.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials

Showing 5 of 5

completed

Comparison of the Performance and Effectiveness of Two Transfusion-Saving Devices: Cell-Saver and SAME

NCT06766032

completednot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT06766032

Comparison of the Performance and Effectiveness of Two Transfusion-Saving Devices: Cell-Saver and SAME

Completed

NCT00762268Not Applicable

A Trial of SAMe for Treatment-Resistant Bipolar Depression

Completed

NCT00070941Phase 2

SAM-e for the Treatment of Depression in Patients With Parkinson's Disease

Completed

NCT00284011Not Applicable

Effect of the Dietary Supplement SAMe on Blood Homocysteine Levels

Completed

NCT00851981Phase 2

Randomized, Controlled Trial of S-adenosylmethionine in Alcoholic Liver Disease

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5